Arcadia Biosciences, Inc. (RKDA) - Q3 2025 10-Q Summary
Business Context and Reporting Period
This summary covers the quarterly period ended September 30, 2025. Arcadia Biosciences, Inc. is a non-accelerated filer and smaller reporting company. The company has transitioned from a wheat-focused biotechnology firm to a consumer goods company primarily deriving revenue from its Zola coconut water brand. The GoodWheat brand was sold in May 2024 and is reported as a discontinued operation. The company is currently pursuing a business combination with Roosevelt Resources LP, with a registration statement (Form S-4) under SEC review.
Key Financial Metrics
| Metric | Q3 2025 (3 Months) | Q3 2024 (3 Months) | YTD 2025 (9 Months) | YTD 2024 (9 Months) |
|---|---|---|---|---|
| Total Revenue | $1.302 million | $1.537 million | $3.957 million | $3.829 million |
| Net Income (Loss) | $0.856 million | $(1.612) million | $(1.003) million | $(2.974) million |
| Operating Loss | $(1.152) million | $(1.760) million | $(1.125) million | $(1.369) million |
| Cash & Equivalents | $1.120 million | $3.936 million | $1.120 million | $3.936 million |
| Working Capital | $6.102 million | $6.679 million | $6.102 million | $6.679 million |
| Accumulated Deficit | $(279.881) million | $(274.814) million | $(279.881) million | $(274.814) million |
Note: Q3 2025 Net Income was driven by non-operating gains, including a $1.7 million unrealized gain on Above Food Ingredients, Inc. (AFII) stock and a $0.56 million gain on warrant liabilities. Operating loss narrowed due to reduced SG&A expenses.
Material Changes vs. Prior Period
- Revenue: Q3 2025 revenue decreased 15% year-over-year, primarily due to the absence of GLA oil sales in 2025. YTD revenue increased 3% driven by higher Zola coconut water volume.
- Profitability: The company reported a net profit in Q3 2025 compared to a loss in Q3 2024. This reversal is largely attributable to non-cash gains: a $1.7 million unrealized gain on AFII stock and a $0.56 million gain from the change in fair value of warrant liabilities. Operating expenses decreased significantly (SG&A down 30% QoQ) due to reduced headcount and operating costs.
- Credit Loss: A significant $4.745 million credit loss was recorded YTD 2025 (including $0.257 million in Q3) related to the promissory note from Above Food Corp. The company determined the remaining principal and accrued interest were unlikely to be collected due to Above Food's receivership.
- Asset Sales: The company recorded a $0.75 million gain in Q1 2025 from the sale of reduced gluten and oxidative stability patents to Bioceres Crop Solutions Corp. (BIOX).
- Contingent Liability: A $2.0 million contingent liability related to the Anawah acquisition was eliminated in Q2 2025 following the abandonment of a technology program.
Outlook, Risks, and Contingencies
- Going Concern: Management has raised substantial doubt about the company's ability to continue as a going concern. With only $1.1 million in cash and cash equivalents, the company believes existing resources are insufficient to meet anticipated requirements for the next 12 months.
- Liquidity Strategy: The company is seeking additional funding through debt or equity financings, asset sales, or the sale of AFII shares. The sale of AFII shares is subject to Rule 144 restrictions and market volatility.
- Roosevelt Transaction: The proposed exchange with Roosevelt Resources LP remains pending SEC review. If completed, Roosevelt partners would own 90% of the company.
- Legal Proceedings: The company is defending against a Proposition 65 lawsuit regarding BPA in coconut water containers filed by the Center for Environmental Health. Additionally, stockholders have sent demand letters alleging deficiencies in the proxy statement for the Roosevelt transaction.
- Tariffs: New U.S. tariffs on Asian sourcing countries (approx. 20%) may increase the cost of goods sold for Zola products, though the full impact remains uncertain.
Investor Verification Checklist
- Cash Runway: Verify the sufficiency of the $1.1 million cash balance against monthly burn rates and the timeline for the Roosevelt transaction closing.
- Above Food Receivable: Confirm the status of the $4.0 million defaulted note receivable and the likelihood of recovering value through the issuance of additional AFII shares.
- AFII Stock Liquidity: Assess the marketability and valuation of the AFII shares held by Arcadia, including Rule 144 holding period requirements and potential resale restrictions.
- Roosevelt Deal Status: Monitor the SEC review of the Form S-4 registration statement and any potential delays or terminations of the exchange agreement.
- Legal Exposure: Track the progress of the Proposition 65 litigation and the stockholder demand letters regarding the Roosevelt transaction disclosures.